share_log

RBC Raises Price Target on WAVE Life Sciences to $7 From $5, Keeps Sector Perform Rating, Speculative Risk

RBC Raises Price Target on WAVE Life Sciences to $7 From $5, Keeps Sector Perform Rating, Speculative Risk

RBC将wave life sciences的目标股价从5美元上调至7美元,保持板块表现评级,具有投机风险
MT Newswires ·  10/04 07:30  · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发